Literature DB >> 30693384

Optimal duration of treatment with eculizumab in atypical hemolytic uremic syndrome (aHUS)-a question to be addressed in a scientific way.

Gema Ariceta1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30693384     DOI： 10.1007/s00467-019-4192-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  52 in total

1.  Management of hemolytic uremic syndrome.

Authors:  Chantal Loirat; Jeffrey Saland; Martin Bitzan
Journal:  Presse Med       Date:  2012-01-27       Impact factor: 1.228

2.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors:  Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

3.  Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome: an update.

Authors:  Gianluigi Ardissino; Francesca Tel; Martina Sgarbanti; Donata Cresseri; Antenore Giussani; Samantha Griffini; Elena Grovetto; Ilaria Possenti; Michela Perrone; Sara Testa; Fabio Paglialonga; Piergiorgio Messa; Massimo Cugno
Journal:  Pediatr Nephrol       Date:  2017-10-18       Impact factor: 3.714

4.  Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.

Authors:  M Scully; S Cataland; P Coppo; J de la Rubia; K D Friedman; J Kremer Hovinga; B Lämmle; M Matsumoto; K Pavenski; E Sadler; R Sarode; H Wu
Journal:  J Thromb Haemost       Date:  2017-01-30       Impact factor: 5.824

5.  Sensitive, reliable and easy-performed laboratory monitoring of eculizumab therapy in atypical hemolytic uremic syndrome.

Authors:  Elena B Volokhina; Nicole C A J van de Kar; Grethe Bergseth; Thea J A M van der Velden; Dineke Westra; Jack F M Wetzels; Lambertus P van den Heuvel; Tom Eirik Mollnes
Journal:  Clin Immunol       Date:  2015-06-23       Impact factor: 3.969

6.  Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases.

Authors:  Gianluigi Ardissino; Sara Testa; Ilaria Possenti; Francesca Tel; Fabio Paglialonga; Stefania Salardi; Silvana Tedeschi; Mirco Belingheri; Massimo Cugno
Journal:  Am J Kidney Dis       Date:  2014-03-19       Impact factor: 8.860

7.  Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome.

Authors:  Anna Richards; Elizabeth J Kemp; M Kathryn Liszewski; Judith A Goodship; Anne K Lampe; Ronny Decorte; M Hamza Müslümanoğlu; Salih Kavukcu; Guido Filler; Yves Pirson; Leana S Wen; John P Atkinson; Timothy H J Goodship
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

8.  An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.

Authors:  Josep M Campistol; Manuel Arias; Gema Ariceta; Miguel Blasco; Laura Espinosa; Mario Espinosa; Josep M Grinyó; Manuel Macía; Santiago Mendizábal; Manuel Praga; Elena Román; Roser Torra; Francisco Valdés; Ramón Vilalta; Santiago Rodríguez de Córdoba
Journal:  Nefrologia       Date:  2015-10-09       Impact factor: 2.033

9.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Authors:  Véronique Fremeaux-Bacchi; Fadi Fakhouri; Arnaud Garnier; Frank Bienaimé; Marie-Agnès Dragon-Durey; Stéphanie Ngo; Bruno Moulin; Aude Servais; François Provot; Lionel Rostaing; Stéphane Burtey; Patrick Niaudet; Georges Deschênes; Yvon Lebranchu; Julien Zuber; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237

10.  Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

Authors:  Timothy H J Goodship; H Terence Cook; Fadi Fakhouri; Fernando C Fervenza; Véronique Frémeaux-Bacchi; David Kavanagh; Carla M Nester; Marina Noris; Matthew C Pickering; Santiago Rodríguez de Córdoba; Lubka T Roumenina; Sanjeev Sethi; Richard J H Smith
Journal:  Kidney Int       Date:  2016-12-16       Impact factor: 10.612
View more
  7 in total

1.  Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study.

Authors:  Esra Baskin; Kibriya Fidan; Bora Gulhan; Kaan Gulleroglu; Nur Canpolat; Alev Yilmaz; Gonül Parmakiz; Zeynep Birsin Özçakar; Fatih Ozaltin; Oguz Soylemezoglu
Journal:  J Nephrol       Date:  2022-01-21       Impact factor: 3.902

2.  Complement inhibitor eculizumab in thrombotic microangiopathy: Single-center case series.

Authors:  Monika Vitkauskaitė; Artūras Vinikovas; Marius Miglinas; Laurynas Rimševičius; Agnė Čerkauskaitė; Ernesta Mačionienė; Eglė Ašakienė
Journal:  Clin Case Rep       Date:  2022-03-15

3.  Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes.

Authors:  Gema Ariceta; Fadi Fakhouri; Lisa Sartz; Benjamin Miller; Vasilis Nikolaou; David Cohen; Andrew M Siedlecki; Gianluigi Ardissino
Journal:  Clin Kidney J       Date:  2021-01-24

4.  Successful Discontinuation of Eculizumab in a Pediatric Patient With Atypical Hemolytic Uremic Syndrome and Underlying Systematic Lupus Erythematosus.

Authors:  Issa Alhamoud; Sydney A Freiberg
Journal:  Cureus       Date:  2022-05-18

5.  Utility Values Associated with Atypical Hemolytic Uremic Syndrome-Related Attributes: A Discrete Choice Experiment in Five Countries.

Authors:  Kate Williams; Daniel Aggio; Peter Chen; Katerina Anokhina; Andrew J Lloyd; Yan Wang
Journal:  Pharmacoeconomics       Date:  2021-07-01       Impact factor: 4.981

6.  Optimal management of atypical hemolytic uremic disease: challenges and solutions.

Authors:  Rupesh Raina; Manpreet K Grewal; Yeshwanter Radhakrishnan; Vineeth Tatineni; Meredith DeCoy; Linda Lg Burke; Arvind Bagga
Journal:  Int J Nephrol Renovasc Dis       Date:  2019-09-04

7.  Neonatal Atypical Hemolytic Uremic Syndrome in the Eculizumab Era.

Authors:  Sara Madureira Gomes; Rita Pissarra Teixeira; Gustavo Rocha; Paulo Soares; Hercilia Guimaraes; Paulo Santos; Joana Jardim; João Luís Barreira; Helena Pinto
Journal:  AJP Rep       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.